Latest Mothaffar Rimawi Stories
Is the era of targeted therapy for breast cancer at hand?
A subset of breast cancer patients who have tumors overexpressing a protein called the human epidermal growth factor receptor 2 (HER-2 positive) may benefit from a combination of targeted treatments and may not need chemotherapy.
With a recently announced $125,000 grant, the Houston Affiliate of Susan G. Komen for the CureÂ© will continue its support of physicians in the Lester and Sue Smith Breast Center at Baylor College of Medicine who provide breast cancer care to Houston's medically underserved and uninsured at Ben Taub General Hospital.
Breast cancer patients who have triple negative breast cancer, an aggressive form of the disease, that has spread to other parts of the body, are being asked to participate in a clinical study of a promising new treatment called PARP inhibitors.
- A hairdresser.